You just read:

Ardelyx Regains Worldwide Development and Commercialization Rights for Its Late-Stage Development Candidate, Tenapanor, and Related Portfolio of NHE3 Compounds

News provided by

Ardelyx

Jun 03, 2015, 06:19 ET